• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于从含有本土细菌的口腔标本中检测放线菌属和 Schaalia 属的选择性分离培养基的开发。

Development of selective isolation media for detecting the genera Actinomyces and Schaalia from oral specimens containing indigenous bacteria.

作者信息

Aoki Sadao, Yahara Hiroko, Nakao Ryoma, Tsuzukibashi Osamu, Yahara Koji

机构信息

Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

Genome Medical Science Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

出版信息

Access Microbiol. 2024 May 10;6(5). doi: 10.1099/acmi.0.000768.v3. eCollection 2024.

DOI:10.1099/acmi.0.000768.v3
PMID:38868375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11165599/
Abstract

To isolate specific bacteria from samples constituting the microbiota, it is essential to employ selective media that suppress the growth of resident bacteria other than specific target bacteria. Selective media for clinically important (including , which was previously taxonomically classified as part of the genus ) have been limited because they have been designed for a limited range of species within the genus and require ingredients which are difficult to prepare and handle. This study aimed to develop a selective medium [referred to as and Selective Medium (ASSM)] for the isolation of a broad range of and species from samples mixed with resident bacteria. The composition of ASSM includes yeast extract, agar, brain heart infusion (BHI), levofloxacin (LVFX), fosfomycin (FOM), colistin (CL) and metronidazole (MNZ). Evaluation of the medium using 24 swab samples serially collected from the roots of the teeth of a healthy individual for whom metagenome sequencing data of a saliva sample are publicly available revealed that ASSM adjusted to concentrations of LVFX 0.5 mg l, FOM 5 mg l, CL 1 mg l and MNZ 2 mg l and cultured anaerobically at 35 °C for 7 days enabled the isolation of species from 37.5 % of the samples. The inclusion of CL and MNZ in ASSM can also be useful for samples harbouring other bacterial species. The selective isolation medium is expected to contribute to studies investigating the relationship between these bacteria and their pathogenesis or disease.

摘要

为了从构成微生物群的样本中分离出特定细菌,使用能够抑制特定目标细菌以外的常驻细菌生长的选择性培养基至关重要。用于临床上重要的(包括以前在分类学上被归类为属一部分的)的选择性培养基一直很有限,因为它们是为该属内有限范围的物种设计的,并且需要难以制备和处理的成分。本研究旨在开发一种选择性培养基[称为和选择性培养基(ASSM)],用于从与常驻细菌混合的样本中分离出广泛的和物种。ASSM的组成包括酵母提取物、琼脂、脑心浸液(BHI)、左氧氟沙星(LVFX)、磷霉素(FOM)、黏菌素(CL)和甲硝唑(MNZ)。使用从一名健康个体的牙齿根部连续采集的24个拭子样本对该培养基进行评估,该个体唾液样本的宏基因组测序数据已公开,结果显示,将ASSM调整为LVFX浓度0.5mg/l、FOM浓度5mg/l、CL浓度1mg/l和MNZ浓度2mg/l,并在35°C厌氧培养7天,能够从37.5%的样本中分离出物种。在ASSM中加入CL和MNZ对含有其他细菌物种的样本也可能有用。这种选择性分离培养基有望为研究这些细菌与其发病机制或疾病之间的关系做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67df/11165599/06edee8f5be3/acmi-6-00768-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67df/11165599/baa3c3fe30ec/acmi-6-00768-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67df/11165599/06edee8f5be3/acmi-6-00768-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67df/11165599/baa3c3fe30ec/acmi-6-00768-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67df/11165599/06edee8f5be3/acmi-6-00768-g002.jpg

相似文献

1
Development of selective isolation media for detecting the genera Actinomyces and Schaalia from oral specimens containing indigenous bacteria.用于从含有本土细菌的口腔标本中检测放线菌属和 Schaalia 属的选择性分离培养基的开发。
Access Microbiol. 2024 May 10;6(5). doi: 10.1099/acmi.0.000768.v3. eCollection 2024.
2
Isolation and identification methods of Rothia species in oral cavities.口腔中露西菌属菌种的分离与鉴定方法
J Microbiol Methods. 2017 Mar;134:21-26. doi: 10.1016/j.mimet.2017.01.005. Epub 2017 Jan 10.
3
Polymicrobial infections with specific and related organisms, using the current taxonomy.使用当前分类法的特定及相关生物体的多微生物感染。
J Oral Microbiol. 2024 May 16;16(1):2354148. doi: 10.1080/20002297.2024.2354148. eCollection 2024.
4
New medium for isolation of Actinomyces viscosus and Actinomyces naeslundii from dental plaque.用于从牙菌斑中分离粘性放线菌和内氏放线菌的新培养基。
J Clin Microbiol. 1978 Jun;7(6):514-8. doi: 10.1128/jcm.7.6.514-518.1978.
5
Genome characterisation and comparative analysis of Schaalia dentiphila sp. nov. and its subspecies, S. dentiphila subsp. denticola subsp. nov., from the human oral cavity.从人类口腔中分离的新型齿双歧 Schaalia dentiphila 及其亚种齿双歧亚种 denticola 的基因组特征和比较分析。
BMC Microbiol. 2024 May 28;24(1):185. doi: 10.1186/s12866-024-03346-w.
6
A selective medium for the isolation of Microbacterium species in oral cavities.一种用于分离口腔中微杆菌属菌种的选择性培养基。
J Microbiol Methods. 2015 Sep;116:60-5. doi: 10.1016/j.mimet.2015.06.016. Epub 2015 Jul 4.
7
A novel selective medium for the isolation and distribution of Rothia dentocariosa in oral cavities.一种用于口腔中罗氏菌选择性分离和分布的新型培养基。
J Microbiol Methods. 2012 Oct;91(1):205-7. doi: 10.1016/j.mimet.2012.07.004. Epub 2012 Jul 11.
8
Experience with a novel selective medium for isolation of Actinomyces spp. from medical and dental specimens.一种用于从医学和牙科标本中分离放线菌属的新型选择性培养基的经验。
J Clin Microbiol. 1995 Jun;33(6):1613-6. doi: 10.1128/jcm.33.6.1613-1616.1995.
9
Antibiotic content of selective culture media for isolation of Capnocytophaga species from oral polymicrobial samples.从口腔多微生物样本中分离嗜二氧化碳噬纤维菌属的选择性培养基于抗生素含量。
Lett Appl Microbiol. 2013 Oct;57(4):303-9. doi: 10.1111/lam.12112. Epub 2013 Jun 20.
10
In vitro culture of previously uncultured oral bacterial phylotypes.未培养口腔细菌系统型的体外培养
Appl Environ Microbiol. 2015 Dec;81(24):8307-14. doi: 10.1128/AEM.02156-15. Epub 2015 Sep 25.

本文引用的文献

1
Role of Actinomyces spp. and related organisms in the development of medication-related osteonecrosis of the jaw (MRONJ): Clinical evidence based on a case series.放线菌属及相关微生物在药物性颌骨坏死(MRONJ)发生发展中的作用:基于病例系列的临床证据
Eur J Microbiol Immunol (Bp). 2023 Dec 1;13(4):125-134. doi: 10.1556/1886.2023.00041. Print 2023 Dec 21.
2
Long-read metagenomics using PromethION uncovers oral bacteriophages and their interaction with host bacteria.基于 PromethION 的长读宏基因组学揭示了口腔噬菌体及其与宿主细菌的相互作用。
Nat Commun. 2021 Jan 4;12(1):27. doi: 10.1038/s41467-020-20199-9.
3
Shotgun metagenome sequencing identification of a set of genes encoded by Actinomyces associated with medication-related osteonecrosis of the jaw.
通过 shotgun 宏基因组测序鉴定与药物相关性颌骨坏死相关的放线菌编码的一组基因。
PLoS One. 2020 Nov 30;15(11):e0241676. doi: 10.1371/journal.pone.0241676. eCollection 2020.
4
Actinomyces and MRONJ: A retrospective study and a literature review.放线菌与放射性颌骨坏死:一项回顾性研究及文献综述。
J Stomatol Oral Maxillofac Surg. 2021 Nov;122(5):499-504. doi: 10.1016/j.jormas.2020.07.012. Epub 2020 Aug 20.
5
Genome-Based Taxonomic Classification of the Phylum .基于基因组的门的分类学分类 。
Front Microbiol. 2018 Aug 22;9:2007. doi: 10.3389/fmicb.2018.02007. eCollection 2018.
6
Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada.静脉注射磷霉素:对其在加拿大用于治疗全身性感染的潜力评估。
Can J Infect Dis Med Microbiol. 2018 Jun 25;2018:8912039. doi: 10.1155/2018/8912039. eCollection 2018.
7
The Combination of Fosfomycin, Metronidazole, and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor is Stable in vitro and Has Maintained Antibacterial Activity.磷霉素、甲硝唑与重组人粒细胞巨噬细胞集落刺激因子联合使用在体外稳定且保持抗菌活性。
Drug Res (Stuttg). 2018 Jun;68(6):349-354. doi: 10.1055/s-0043-123933. Epub 2017 Dec 19.
8
Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015.日本外科手术部位感染分离病原菌的抗菌药物敏感性:2010年及2014 - 2015年全国监测研究数据比较
J Infect Chemother. 2017 Jun;23(6):339-348. doi: 10.1016/j.jiac.2017.03.010. Epub 2017 Apr 5.
9
Resistance patterns in clinical isolates of pathogenic Actinomyces species.致病性放线菌临床分离株的耐药模式。
J Antimicrob Chemother. 2016 Feb;71(2):422-7. doi: 10.1093/jac/dkv347. Epub 2015 Nov 3.
10
Actinomyces and related organisms in human infections.放线菌及相关微生物在人类感染中的情况。
Clin Microbiol Rev. 2015 Apr;28(2):419-42. doi: 10.1128/CMR.00100-14.